Efficacy of Mobile-delivered Sleep Restriction Therapy for Treatment of Insomnia Disorder: Randomised Controlled Trial - Trial NCT06114901
Access comprehensive clinical trial information for NCT06114901 through Pure Global AI's free database. This phase not specified trial is sponsored by Woolcock Institute of Medical Research and is currently Not yet recruiting. The study focuses on Insomnia. Target enrollment is 558 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Woolcock Institute of Medical Research
Timeline & Enrollment
N/A
Nov 10, 2023
Oct 26, 2028
Primary Outcome
Insomnia symptom severity
Summary
The SleepFix Study is a clinical trial designed to evaluate the efficacy of
 mobile-delivered sleep restriction therapy (dBTi) in comparison to digital sleep health
 education (control) for treating insomnia disorder in adults aged 18 and above. The study is
 conducted entirely online, with 558 participants (279 in each group) and aims to determine
 the impact of the interventions on insomnia symptom severity, sleep metrics, subjective sleep
 quality, fatigue, anxiety, depressive symptoms, quality of life, medication usage, and
 workforce productivity.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06114901
Non-Device Trial